BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ogino S, King EE, Beck AH, Sherman ME, Milner DA, Giovannucci E. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am J Epidemiol 2012;176:659-67. [PMID: 22935517 DOI: 10.1093/aje/kws226] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Ogino S, Campbell PT, Nishihara R, Phipps AI, Beck AH, Sherman ME, Chan AT, Troester MA, Bass AJ, Fitzgerald KC, Irizarry RA, Kelsey KT, Nan H, Peters U, Poole EM, Qian ZR, Tamimi RM, Tchetgen Tchetgen EJ, Tworoger SS, Zhang X, Giovannucci EL, van den Brandt PA, Rosner BA, Wang M, Chatterjee N, Begg CB. Proceedings of the second international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control 2015;26:959-72. [PMID: 25956270 DOI: 10.1007/s10552-015-0596-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
2 Kuroiwa-Trzmielina J, Wang F, Rapkins RW, Ward RL, Buchanan DD, Win AK, Clendenning M, Rosty C, Southey MC, Winship IM, Hopper JL, Jenkins MA, Olivier J, Hawkins NJ, Hitchins MP. SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer. Clin Cancer Res 2016;22:6266-77. [PMID: 27267851 DOI: 10.1158/1078-0432.CCR-15-2765] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
3 Morikawa T, Kuchiba A, Lochhead P, Nishihara R, Yamauchi M, Imamura Y, Liao X, Qian ZR, Ng K, Chan AT. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status. Cancer Res. 2013;73:1600-1610. [PMID: 23442321 DOI: 10.1158/0008-5472.can-12-2276] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
4 Mima K, Kosumi K, Baba Y, Hamada T, Baba H, Ogino S. The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor-immune-microbiome interaction. Hum Genet 2021;140:725-46. [PMID: 33180176 DOI: 10.1007/s00439-020-02235-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
5 Nishi A, Kawachi I, Koenen KC, Wu K, Nishihara R, Ogino S. Lifecourse epidemiology and molecular pathological epidemiology. Am J Prev Med. 2015;48:116-119. [PMID: 25528613 DOI: 10.1016/j.amepre.2014.09.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ryan BM, Wolff RK, Valeri N, Khan M, Robinson D, Paone A, Bowman ED, Lundgreen A, Caan B, Potter J. An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer. Cancer Epidemiol. 2014;38:583-590. [PMID: 25132422 DOI: 10.1016/j.canep.2014.07.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
7 Kuller LH. Epidemiology: Then and Now. Am J Epidemiol 2016;183:372-80. [PMID: 26493266 DOI: 10.1093/aje/kwv158] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
8 Bauer KC, Rees T, Finlay BB. The Gut Microbiota-Brain Axis Expands Neurologic Function: A Nervous Rapport. Bioessays 2019;41:e1800268. [PMID: 31099408 DOI: 10.1002/bies.201800268] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
9 Kornilov SA. Commentary-child and adolescent development in the focus of emerging developmental science. New Dir Child Adolesc Dev 2015;2015:117-21. [PMID: 25732023 DOI: 10.1002/cad.20079] [Reference Citation Analysis]
10 Monteiro S, Gonçalves TC, Magalhães J, Cotter J. Upper gastrointestinal bleeding risk scores: Who, when and why? World J Gastrointest Pathophysiol 2016;7:86-96. [PMID: 26909231 DOI: 10.4291/wjgp.v7.i1.86] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
11 Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene. 2014;33:2949-2955. [PMID: 23792451 DOI: 10.1038/onc.2013.244] [Cited by in Crossref: 83] [Cited by in F6Publishing: 82] [Article Influence: 10.4] [Reference Citation Analysis]
12 Hamada T, Keum N, Nishihara R, Ogino S. Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. J Gastroenterol. 2017;52:265-275. [PMID: 27738762 DOI: 10.1007/s00535-016-1272-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 13.0] [Reference Citation Analysis]
13 Epplein M, Bostick RM, Mu L, Ogino S, Braithwaite D, Kanetsky PA. Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report. Cancer Epidemiol Biomarkers Prev. 2014;23:2613-2617. [PMID: 25277796 DOI: 10.1158/1055-9965.epi-14-0848] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kuller LH. Invited commentary: the 21st century epidemiologist--a need for different training? Am J Epidemiol 2012;176:668-71. [PMID: 22935514 DOI: 10.1093/aje/kws227] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
15 Lam TK, Spitz M, Schully SD, Khoury MJ. "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev 2013;22:181-8. [PMID: 23322363 DOI: 10.1158/1055-9965.EPI-12-1262] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
16 Sethi S, Ali S, Philip PA, Sarkar FH. Clinical advances in molecular biomarkers for cancer diagnosis and therapy. Int J Mol Sci 2013;14:14771-84. [PMID: 23863689 DOI: 10.3390/ijms140714771] [Cited by in F6Publishing: 39] [Reference Citation Analysis]
17 Lochhead P, Chan AT, Giovannucci E, Fuchs CS, Wu K, Nishihara R, O'Brien M, Ogino S. Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions. Am J Gastroenterol 2014;109:1205-14. [PMID: 24935274 DOI: 10.1038/ajg.2014.153] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
18 Sun Y, Zhang Z, Zheng CQ, Sang LX. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review. World J Gastroenterol 2021;27:2963-78. [PMID: 34168401 DOI: 10.3748/wjg.v27.i22.2963] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Braconi D, Bernardini G, Spiga O, Santucci A. Leveraging proteomics in orphan disease research: pitfalls and potential. Expert Rev Proteomics 2021;18:315-27. [PMID: 33861161 DOI: 10.1080/14789450.2021.1918549] [Reference Citation Analysis]
20 Hamada T, Nowak JA, Milner DA jr. Song M, Ogino S. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms. J Pathol. 2019;247:615-628. [PMID: 30632609 DOI: 10.1002/path.5236] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 24.0] [Reference Citation Analysis]
21 Hanyuda A, Kim SA, Martinez-Fernandez A, Qian ZR, Yamauchi M, Nishihara R, Morikawa T, Liao X, Inamura K, Mima K, Cao Y, Zhang X, Wu K, Chan AT, Giovannucci EL, Meyerhardt JA, Fuchs CS, Shivdasani RA, Ogino S. Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer. Ann Surg Oncol. 2016;23:908-917. [PMID: 26577117 DOI: 10.1245/s10434-015-4967-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
22 Spitz MR, Lam TK, Schully SD, Khoury MJ. The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists. Am J Epidemiol 2014;180:964-7. [PMID: 25234430 DOI: 10.1093/aje/kwu256] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
23 Holmes E, Wijeyesekera A, Taylor-Robinson SD, Nicholson JK. The promise of metabolic phenotyping in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2015;12:458-71. [PMID: 26194948 DOI: 10.1038/nrgastro.2015.114] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
24 Nishihara R, Morikawa T, Kuchiba A, Lochhead P, Yamauchi M, Liao X, Imamura Y, Nosho K, Shima K, Kawachi I. A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification. Am J Epidemiol. 2013;178:84-100. [PMID: 23788674 DOI: 10.1093/aje/kws431] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 8.1] [Reference Citation Analysis]
25 Nishi A, Milner DA Jr, Giovannucci EL, Nishihara R, Tan AS, Kawachi I, Ogino S. Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Rev Mol Diagn 2016;16:11-23. [PMID: 26636627 DOI: 10.1586/14737159.2016.1115346] [Cited by in Crossref: 64] [Cited by in F6Publishing: 45] [Article Influence: 10.7] [Reference Citation Analysis]
26 Sylvetsky AC, Nandagopal R, Nguyen TT, Abegg MR, Nagarur M, Kaplowitz P, Rother KI. Buddy Study: Partners for better health in adolescents with type 2 diabetes. World J Diabetes 2015;6:1355-62. [PMID: 26722619 DOI: 10.4239/wjd.v6.i18.1355] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
27 Kyriazis M. Translating laboratory anti-aging biotechnology into applied clinical practice: Problems and obstacles. WJTM 2015;4:51. [DOI: 10.5528/wjtm.v4.i2.51] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
28 Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol 2013;26:465-84. [PMID: 23307060 DOI: 10.1038/modpathol.2012.214] [Cited by in Crossref: 151] [Cited by in F6Publishing: 138] [Article Influence: 18.9] [Reference Citation Analysis]
29 Lewis C, McQuaid S, Hamilton PW, Salto-Tellez M, McArt D, James JA. Building a 'Repository of Science': The importance of integrating biobanks within molecular pathology programmes. Eur J Cancer 2016;67:191-9. [PMID: 27677055 DOI: 10.1016/j.ejca.2016.08.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
30 Ogino S, Nowak JA, Hamada T, Phipps AI, Peters U, Milner DA, Giovannucci EL, Nishihara R, Giannakis M, Garrett WS, Song M. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. Gut. 2018;67:1168-1180. [PMID: 29437869 DOI: 10.1136/gutjnl-2017-315537] [Cited by in Crossref: 93] [Cited by in F6Publishing: 81] [Article Influence: 31.0] [Reference Citation Analysis]
31 Dai J, Nishi A, Tran N, Yamamoto Y, Dewey G, Ugai T, Ogino S. Revisiting social MPE: an integration of molecular pathological epidemiology and social science in the new era of precision medicine. Expert Rev Mol Diagn 2021;:1-18. [PMID: 34253130 DOI: 10.1080/14737159.2021.1952073] [Reference Citation Analysis]
32 Wang M, Kuchiba A, Ogino S. A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers. Am J Epidemiol 2015;182:263-70. [PMID: 26116215 DOI: 10.1093/aje/kwv040] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
33 Kuller LH. Epidemiologists of the Future: Data Collectors or Scientists? Am J Epidemiol 2019;188:890-5. [PMID: 30877293 DOI: 10.1093/aje/kwy221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
34 Sridharan G, Ramani P, Patankar S, Vijayaraghavan R. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma. J Oral Pathol Med 2019;48:299-306. [PMID: 30714209 DOI: 10.1111/jop.12835] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
35 Nishi A, Kawachi I, Koenen KC, Wu K, Nishihara R, Ogino S. Lifecourse epidemiology and molecular pathological epidemiology. Am J Prev Med. 2015;48:116-119. [PMID: 25528613 DOI: 10.1016/j.amepre.2014.09.031.4274745] [Reference Citation Analysis]
36 Ogino S, Nowak JA, Hamada T, Milner DA Jr, Nishihara R. Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology. Annu Rev Pathol. 2019;14:83-103. [PMID: 30125150 DOI: 10.1146/annurev-pathmechdis-012418-012818] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 29.0] [Reference Citation Analysis]
37 Nishihara R, VanderWeele TJ, Shibuya K, Mittleman MA, Wang M, Field AE, Giovannucci E, Lochhead P, Ogino S. Molecular pathological epidemiology gives clues to paradoxical findings. Eur J Epidemiol 2015;30:1129-35. [PMID: 26445996 DOI: 10.1007/s10654-015-0088-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
38 Ogino S, Jhun I, Mata DA, Soong TR, Hamada T, Liu L, Nishihara R, Giannakis M, Cao Y, Manson JE, Nowak JA, Chan AT. Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology. NPJ Precis Oncol 2017;1:40. [PMID: 29552640 DOI: 10.1038/s41698-017-0042-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
39 Hagland HR, Søreide K. Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways. Cancer Lett 2015;356:273-80. [PMID: 24614287 DOI: 10.1016/j.canlet.2014.02.026] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
40 Lochhead P, Chan AT, Nishihara R, Fuchs CS, Beck AH, Giovannucci E, Ogino S. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression. Mod Pathol 2015;28:14-29. [PMID: 24925058 DOI: 10.1038/modpathol.2014.81] [Cited by in Crossref: 100] [Cited by in F6Publishing: 98] [Article Influence: 14.3] [Reference Citation Analysis]
41 Diaz-Perez JA, Raju S, Echeverri JH. Evaluation of a teaching strategy based on integration of clinical subjects, virtual autopsy, pathology museum, and digital microscopy for medical students. J Pathol Inform 2014;5:25. [PMID: 25191624 DOI: 10.4103/2153-3539.137729] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
42 Ogino S, Giovannucci E. Commentary: Lifestyle factors and colorectal cancer microsatellite instability--molecular pathological epidemiology science, based on unique tumour principle. Int J Epidemiol 2012;41:1072-4. [PMID: 22596930 DOI: 10.1093/ije/dys076] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
43 Verma M. Molecular profiling and companion diagnostics: where is personalized medicine in cancer heading? Per Med 2014;11:761-71. [PMID: 29764045 DOI: 10.2217/pme.14.41] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
44 Spitz MR, Caporaso NE, Sellers TA. Integrative cancer epidemiology--the next generation. Cancer Discov 2012;2:1087-90. [PMID: 23230187 DOI: 10.1158/2159-8290.CD-12-0424] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
45 Ogino S, Nishihara R, VanderWeele TJ, Wang M, Nishi A, Lochhead P, Qian ZR, Zhang X, Wu K, Nan H, Yoshida K, Milner DA, Chan AT, Field AE, Camargo CA, Williams MA, Giovannucci EL. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. Epidemiology. 2016;27:602-611. [PMID: 26928707 DOI: 10.1097/ede.0000000000000471] [Cited by in Crossref: 116] [Cited by in F6Publishing: 80] [Article Influence: 38.7] [Reference Citation Analysis]
46 Ogino S, Beck AH, King EE, Sherman ME, Milner DA, Giovannucci E. Ogino et Al. Respond to "the 21st century epidemiologist". Am J Epidemiol 2012;176:672-4. [PMID: 22935516 DOI: 10.1093/aje/kws229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
47 Wang S, Wu S, Meng Q, Li X, Zhang J, Chen R, Wang M. FAS rs2234767 and rs1800682 polymorphisms jointly contributed to risk of colorectal cancer by affecting SP1/STAT1 complex recruitment to chromatin. Sci Rep 2016;6:19229. [PMID: 26759270 DOI: 10.1038/srep19229] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
48 Ogino S, Fuchs CS, Giovannucci E. How many molecular subtypes? Implications of the unique tumor principle in personalized medicine. Expert Rev Mol Diagn. 2012;12:621-628. [PMID: 22845482 DOI: 10.1586/erm.12.46] [Cited by in Crossref: 111] [Cited by in F6Publishing: 96] [Article Influence: 12.3] [Reference Citation Analysis]